๐๏ธ Verified NIH Record โข Updated 2026-08-06
Rural Adult and Youth Sun Protection Study (NCT06439979)
Rural Adult and Youth Sun Protection Study - Rural Baseball R01
๐ข Recruiting Observational / Diagnostic ๐ง Behavioral & Psychological Program Sponsor: University of Utah
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to help prevent skin cancer by improving the use of sun protective behaviors among youths living in rural communities in Utah and West Virginia.
Who can join: Review the eligibility criteria below.
Location: University of Utah โ Salt Lake City, Utah
Age range: 3 Years to 7 Years
๐งช Interventions in This Study
- RAYS Intervention (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- University of Utah โ Salt Lake City, Utah
- West Virginia University โ Morgantown, West Virginia
๐ Contact the Study Coordinator
Phone: (801) 585-0303
Email: yelena.wu@utah.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Melanoma (Skin)
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma โ Birmingham, Alabama
- Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma โ Tampa, Florida
- A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma โ Toronto, Ontario
- Zr89 + PET Companion Trial โ Philadelphia, Pennsylvania
- Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma โ Orange, California
- A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors โ La Jolla, California
Explore by condition: All Melanoma (Skin) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.